Glancy Prongay seeks lead plaintiff in PROCEPT BioRobotics securities suit
Glancy Prongay Wolke & Rotter LLP said a securities fraud class action involving PROCEPT BioRobotics Corp. remains open to investors who want to seek lead-plaintiff status.
A PR Newswire notice says Glancy Prongay Wolke & Rotter LLP is seeking investors with losses in PROCEPT BioRobotics Corporation to join a securities fraud class action and seek lead-plaintiff status before Sept. 22, 2026.
The release says the case centers on alleged false or misleading statements about PROCEPT’s business, operations and financial condition. It says investors who believe they were harmed can contact the firm, retain other counsel or do nothing and remain absent class members.
What the notice says
The press release is dated Sept. 1, 2026, and says the lawsuit concerns statements made between Feb. 28, 2024, and Feb. 25, 2026. It alleges PROCEPT used an undisclosed discount program to encourage bulk handpiece orders above procedure demand.
According to the release, that strategy allegedly pulled forward sales from future periods, inflated reported U.S. handpiece unit sales and revenues, and contributed to excess customer inventory. The notice also says customer handpiece orders exceeded underlying procedure demand throughout the class period and that the gap widened over time.
The release further alleges the surplus of U.S. handpiece sales relative to procedures created overstocking among customers, totaling more than 10,000 excess units by the end of the class period. It says the alleged result was overstated handpiece unit sales and higher reported utilization of field systems.
Background and context
The notice identifies the matter as a securities fraud class action. It says no class has been certified yet. It also says investors may choose whether to seek appointment as lead plaintiff, retain counsel of their choice or do nothing and stay in the case as absent class members.
The release does not include a response from PROCEPT BioRobotics. The claims in the notice are allegations made in court filings and in the law firm’s announcement, and they have not been proven in the release itself.
What happens next
Under the notice, any investor seeking to serve as lead plaintiff must move the court no later than Sept. 22, 2026. The case will then proceed through the court process unless it is resolved or changed by later filings.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()